Home/Filings/4/0000899243-22-006419
4//SEC Filing

Baeuerle Patrick 4

Accession 0000899243-22-006419

CIK 0001789972other

Filed

Feb 14, 7:00 PM ET

Accepted

Feb 15, 4:48 PM ET

Size

8.5 KB

Accession

0000899243-22-006419

Insider Transaction Report

Form 4
Period: 2022-02-11
Baeuerle Patrick
See Remarks
Transactions
  • Award

    Common Stock

    2022-02-11+37,50037,500 total
  • Award

    Stock Option (Right to Buy)

    2022-02-11+75,00075,000 total
    Exercise: $13.60Exp: 2032-02-10Common Stock (75,000 underlying)
Holdings
  • Common Stock

    (indirect: See footnote)
    341,434
Footnotes (3)
  • [F1]The shares underlying the restricted stock unit vest over four years, with one forty-eighty (1/48th) of the shares vesting in equal monthly installments until the fourth anniversary of the grant date.
  • [F2]Shares held directly by APAK Solutions GmbH. The Reporting Person is managing director of APAK Solutions GmbH. The Reporting Person disclaims beneficial ownership of the securities reported herein except to the extent of his pecuniary interest therein.
  • [F3]The shares underlying the option vest over four years, with one forty-eighty (1/48th) of the shares vesting in equal monthly installments until the fourth anniversary of the grant date.

Issuer

Cullinan Oncology, Inc.

CIK 0001789972

Entity typeother

Related Parties

1
  • filerCIK 0001362054

Filing Metadata

Form type
4
Filed
Feb 14, 7:00 PM ET
Accepted
Feb 15, 4:48 PM ET
Size
8.5 KB